Pharmafile Logo

Peter Impey

- PMLiVE

Red Door appoints Dinning to lead youth engagement

Former Phoenix Consultancy managing director appointed head of new outreach programme

- PMLiVE

Losing the plot?

Influencing beliefs over branding

Tonix appoints head of clinical development

Donald Kellerman has experience at Allergan, Map, Inspire and Glaxo Wellcome

- PMLiVE

Global pancreatic cancer market to treble in value

Celgene's Abraxane will drive rapid growth over next three years

- PMLiVE

GSK terminates lung cancer vaccine trial

Unable to identify patients who may benefit from MAGE-A3 immunotherapy

Icon boost medical device trial capability with Aptiv acquisition

Deal will also enhance the CRO's position inadaptive trials and in Japan

- PMLiVE

Lilly thrown a lifeline on US Alimta patent

Court backs protection from generics until 2022

- PMLiVE

MannKind’s inhaled insulin backed for US approval

Afrezza finally on course for FDA approval in diabetes after two rejections

- PMLiVE

MHRA chairman steps down

Sir Gordon Duff leaves to join Oxford University

Pharma social media

Pharma must step up monitoring of social media

New service intends to help keep track of online patient communications

- PMLiVE

Developing your patient-centric strategy

How to succeed when your vehicle of engagement is not a disease

- PMLiVE

Doctors criticise FDA over Lemtrada rejection

Say Sanofi/Genzyme’s MS drug should have been approved

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links